TY - JOUR
T1 - Cardiovascular prevention
T2 - current gaps and future directions
AU - Dores, Hélder
AU - Santos, José Ferreira
AU - Gil, Victor
AU - Gonçalves, Pedro de Araújo
N1 - Publisher Copyright:
© 2025 by the authors.
PY - 2026/1
Y1 - 2026/1
N2 - Cardiovascular Disease (CVD) remains the leading cause of morbidity and mortality worldwide. Despite significant advances in diagnosis and treatment, the global burden of CVD remains high, underscoring the crucial need for more effective and comprehensive prevention strategies. This narrative overview aims to critically evaluate the current pillars of cardiovascular prevention, identify the gaps in approaches and outline promising future directions. Challenges and barriers in lifestyle adherence and pharmacological management are addressed, while the increasing role of non-traditional and emerging risk factors is discussed. Future directions include maximizing the value of digital health to improve patient engagement and adherence, adopting precision medicine to refine risk stratification and implementing public health policies for population-level interventions. The optimization of cardiovascular prevention requires a multi-level approach that integrates clinical strategies with personalized solutions and environmental policies to ultimately reduce the global impact of CVD.
AB - Cardiovascular Disease (CVD) remains the leading cause of morbidity and mortality worldwide. Despite significant advances in diagnosis and treatment, the global burden of CVD remains high, underscoring the crucial need for more effective and comprehensive prevention strategies. This narrative overview aims to critically evaluate the current pillars of cardiovascular prevention, identify the gaps in approaches and outline promising future directions. Challenges and barriers in lifestyle adherence and pharmacological management are addressed, while the increasing role of non-traditional and emerging risk factors is discussed. Future directions include maximizing the value of digital health to improve patient engagement and adherence, adopting precision medicine to refine risk stratification and implementing public health policies for population-level interventions. The optimization of cardiovascular prevention requires a multi-level approach that integrates clinical strategies with personalized solutions and environmental policies to ultimately reduce the global impact of CVD.
KW - Cardiovascular
KW - Digital
KW - Precision medicine
KW - Prevention
KW - Risk stratification
UR - https://www.scopus.com/pages/publications/105027238703
U2 - 10.3390/diagnostics16010016
DO - 10.3390/diagnostics16010016
M3 - Review article
C2 - 41515511
AN - SCOPUS:105027238703
SN - 2075-4418
VL - 16
JO - Diagnostics
JF - Diagnostics
IS - 1
M1 - 16
ER -